Free Trial
NASDAQ:PETV

PetVivo (PETV) Stock Price, News & Analysis

PetVivo logo
$0.61 0.00 (0.00%)
As of 03:31 PM Eastern

About PetVivo Stock (NASDAQ:PETV)

Key Stats

Today's Range
$0.55
$0.61
50-Day Range
$0.49
$0.80
52-Week Range
$0.29
$1.25
Volume
11,627 shs
Average Volume
22,386 shs
Market Capitalization
$14.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Remove Ads
Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Stock News Headlines

PetVivo closes Series B Convertible Preferred Stock offering
Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Analyzing Apyx Medical (NASDAQ:APYX) & PetVivo (NASDAQ:PETV)
See More Headlines

PETV Stock Analysis - Frequently Asked Questions

PetVivo's stock was trading at $0.62 at the beginning of 2025. Since then, PETV shares have decreased by 1.6% and is now trading at $0.61.
View the best growth stocks for 2025 here
.

PetVivo Holdings, Inc. (NASDAQ:PETV) released its quarterly earnings results on Thursday, June, 29th. The company reported ($0.21) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.21). The firm earned $0.13 million during the quarter. PetVivo had a negative trailing twelve-month return on equity of 4,813.07% and a negative net margin of 902.82%.

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

Last Earnings
6/29/2023
Today
4/07/2025
Next Earnings (Estimated)
6/26/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PETV
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,950,000.00
Net Margins
-902.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.05 million
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-20.33

Miscellaneous

Free Float
19,057,000
Market Cap
$14.51 million
Optionable
Not Optionable
Beta
1.85
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:PETV) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners